Brainomix Presents Robust Validation of Its FDA-Cleared e-Lung Technology from its Collaboration with Boehringer Ingelheim

New studies presented at the American Thoracic Society (ATS) Conference this week validate e-Lung as an accurate tool to identify progressive pulmonary fibrosis OXFORD, England and CHICAGO, May 16, 2025 /PRNewswire/ -- Brainomix, a company pioneering AI-powered imaging solutions in lung...

Read More